HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs (HYDRAFIL-D)
Sponsor: ReGelTec, Inc.
A NA clinical study on Degenerative Disc Disease (DDD), this trial is actively recruiting participants. The trial is conducted by ReGelTec, Inc. and has accumulated 13 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Oct 2025 — Feb 2026 [monthly]
Recruiting NA
-
Jul 2025 — Oct 2025 [monthly]
Recruiting NA
-
Jun 2025 — Jul 2025 [monthly]
Recruiting NA
-
Apr 2025 — Jun 2025 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Feb 2025 — Apr 2025 [monthly]
Recruiting NA
-
Jan 2025 — Feb 2025 [monthly]
Recruiting NA
-
Dec 2024 — Jan 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
Oct 2023 — Jun 2024 [monthly]
Not Yet Recruiting NA
-
Sep 2023 — Oct 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ReGelTec, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .